Radolfzell, Germany

Alexander Mann

This inventor holds 1 USPTO granted patent and 3 published patent applications and 4 EPO patents. Top assignee: Takeda Gmbh. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Mann. Retrieved from https://idiyas.com/inventor/alexander-mann-5j411pya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Alexander Mann

Introduction

Alexander Mann is a notable inventor based in Radolfzell, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development of novel compounds.

Latest Patents

Mann holds a patent for 3,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivatives. This patent describes compounds that serve as effective inhibitors of type 4 and 5 phosphodiesterase. The compounds of Formula (1) are characterized by specific meanings for A, R1, R2, R3, and R5, as detailed in the patent description. He has 1 patent to his name.

Career Highlights

Throughout his career, Mann has worked with prominent companies in the pharmaceutical industry, including Takeda GmbH and AstraZeneca AB. His work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Mann has collaborated with esteemed colleagues such as Dieter Flockerzi and Thomas Stengel, further enhancing the impact of his research and innovations.

Conclusion

Alexander Mann's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of effective therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…